id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-D-0529-0033,FDA,FDA-2010-D-0529,Qualification Process for Drug Development Tools; Guidance for Industry; Availability; Correction,Notice,Notice of Availability,2020-12-11T05:00:00Z,2020,12,2020-12-11T05:00:00Z,,2020-12-11T13:39:39Z,2020-27288,0,0,090000648499804d
FDA-2010-D-0529-0031,FDA,FDA-2010-D-0529,Qualification Process for Drug Development Tools; Guidance for Industry; Availability,Notice,Notice of Availability,2020-11-25T05:00:00Z,2020,11,2020-11-25T05:00:00Z,,2020-11-25T14:16:53Z,2020-26051,0,0,090000648497584a
FDA-2010-D-0529-0032,FDA,FDA-2010-D-0529,Qualification Process for Drug Development Tools; Guidance for Industry and FDA Staff,Other,Guidance,2020-11-25T05:00:00Z,2020,11,2020-11-25T05:00:00Z,,2024-11-06T23:43:20Z,,1,0,0900006484975a81